4//SEC Filing
Oki Mark K 4
Accession 0001567619-22-001304
CIK 0001385818other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 11:42 AM ET
Size
5.1 KB
Accession
0001567619-22-001304
Insider Transaction Report
Form 4
Oki Mark K
Chief Financial Officer
Transactions
- Award
Common Shares
2022-01-17+100,000→ 100,000 total
Footnotes (1)
- [F1]Restricted share grant. One-third of the restricted shares shall vest on January 17, 2023; the remaining restricted shares shall vest quarterly thereafter, at 1/12th of the original grant, with full vesting on January 17, 2025.
Documents
Issuer
AYTU BIOPHARMA, INC
CIK 0001385818
Entity typeother
Related Parties
1- filerCIK 0001491847
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 11:42 AM ET
- Size
- 5.1 KB